Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ankangli Capsules is a traditional Chinese medicine (TCM) formulation developed and manufactured by Zhejiang Kangde Pharmaceutical. It is primarily utilized as an adjuvant therapy for cancer patients undergoing chemotherapy or radiotherapy. The formulation is designed to tonify Qi and blood, strengthen the spleen and kidney, and enhance the body's immune function. Composed of several botanical extracts including *Ganoderma lucidum* (Lingzhi) and *Acanthopanax senticosus*, it works by modulating the immune system and providing antioxidant support to alleviate the systemic toxicities and leukopenia often associated with conventional oncological treatments. It is administered orally and is approved for marketing in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ankangli Capsules.